CN103386008A - Chinese medicine composition for treating endocrine dyscrasia - Google Patents
Chinese medicine composition for treating endocrine dyscrasia Download PDFInfo
- Publication number
- CN103386008A CN103386008A CN2013103132826A CN201310313282A CN103386008A CN 103386008 A CN103386008 A CN 103386008A CN 2013103132826 A CN2013103132826 A CN 2013103132826A CN 201310313282 A CN201310313282 A CN 201310313282A CN 103386008 A CN103386008 A CN 103386008A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- rhizoma
- semen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 230000002124 endocrine Effects 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 210000000582 Semen Anatomy 0.000 claims abstract description 42
- 241000756943 Codonopsis Species 0.000 claims abstract description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 11
- 240000008219 Euryale ferox Species 0.000 claims abstract description 9
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims description 11
- 241000605447 Anemarrhena Species 0.000 claims description 2
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 240000005760 Dioscorea villosa Species 0.000 claims description 2
- 241000218671 Ephedra Species 0.000 claims description 2
- 241001523579 Ostrea Species 0.000 claims description 2
- 241000208966 Polygala Species 0.000 claims description 2
- 241001446509 Psoralea Species 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 235000004879 dioscorea Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 30
- 210000003734 Kidney Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 Blood Anatomy 0.000 abstract description 9
- 210000004185 Liver Anatomy 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 3
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000759833 Cornus officinalis Species 0.000 abstract 1
- 240000005389 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 230000003213 activating Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 11
- 210000000952 Spleen Anatomy 0.000 description 10
- 230000001737 promoting Effects 0.000 description 8
- 230000003014 reinforcing Effects 0.000 description 7
- 238000005728 strengthening Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000668709 Dipterocarpus costatus Species 0.000 description 5
- 210000003205 Muscles Anatomy 0.000 description 5
- 210000001124 Body Fluids Anatomy 0.000 description 4
- 210000000988 Bone and Bones Anatomy 0.000 description 4
- 229940088597 Hormone Drugs 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 229940079593 drugs Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 231100000486 side effect Toxicity 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 210000003491 Skin Anatomy 0.000 description 3
- 210000002784 Stomach Anatomy 0.000 description 3
- 230000001142 anti-diarrhea Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000001502 supplementation Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 230000002936 tranquilizing Effects 0.000 description 3
- 206010002368 Anger Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 210000004072 Lung Anatomy 0.000 description 2
- 231100000614 Poison Toxicity 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000001914 calming Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory Effects 0.000 description 2
- 230000002269 spontaneous Effects 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000006673 Asthma Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010014970 Ephelide Diseases 0.000 description 1
- 210000001061 Forehead Anatomy 0.000 description 1
- 206010062060 Hyperlipidaemia Diseases 0.000 description 1
- 210000000987 Immune System Anatomy 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine zwitterion Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
- 206010024419 Libido decreased Diseases 0.000 description 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010037844 Rash Diseases 0.000 description 1
- 206010043554 Thrombocytopenia Diseases 0.000 description 1
- 229940034208 Thyroxine Drugs 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 201000004384 alopecia Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000002996 emotional Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001076 estrogenic Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229950008325 levothyroxine Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000000422 nocturnal Effects 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Abstract
The invention relates to a Chinese medicine composition for treating endocrine dyscrasia. The Chinese medicine composition comprises the Chinese medicinal materials in parts by weight: 10-30 parts of angelica sinensis, 5-20 parts of rhizoma anemarrhenae, 5-20 parts of radix morindae officinalis, 10-40 parts of herba epimedii, 5-20 parts of rhizoma curculiginis, 10-40 parts of rhizoma dioscoreae, 10-30 parts of jujube kernel, 5-20 parts of polygala tenuifolia, 5-20 parts of fructus schizandrae, 10-40 parts of concha ostreae, 10-30 parts of bighead atractylodes rhizome, 5-25 parts of radix codonopsis, 10-30 parts of poria, 5-25 parts of radix ephedrae, 10-30 parts of cornus officinalis, 5-25 parts of fructus psoraleae, 10-30 parts of semen cuscutae, 10-40 parts of lotus seeds, 10-40 parts of semen euryales, 5-25 parts of the root of kudzu vine, and 5-15 parts of liquorice. The Chinese medicine composition has the effects of tonifying the liver and kidney, benefiting qi, engendering liquid, invigorating the circulation of blood, relieving the stasis, and clearing and activating the channels and collaterals, and is obvious in curative effect on treating endocrine dyscrasia, and reliable to effect.
Description
Technical field
The present invention relates to a kind of not pharmaceutical product of definite structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of the endocrine disturbance.
Background technology
The wide range that the endocrine disturbance comprises, be not a single disease, and it comprises the imbalance of the aspects such as gonadal hormone, adrenocortical hormone, insulin, thyroxine, and all hormones occur extremely can being called the endocrine disturbance.Modern medicine study confirms, the endocrine disturbance is by in body metabolism refuse alluvial body, can not get rid of timely and effectively and form, can cause the skin of face thrombocytopenia, produce auburn abnormal pigmentary deposit on the skin trace,, as diseases such as freckle, chloasma, senile plaque, butterfly spot, melanin depositions, also can bring out the diseases such as disease of immune system, osteoporosis, hyperlipidemia, climacteric syndrome.At present, for the endocrine disturbance, doctor trained in Western medicine is mainly to regulate for endocrine, allows endocrine again reach balance.Too much cause hyperfunctioning for hormone secretion, the method treatment of adopting medicine to suppress and subduing; And, for the very few imbalance patient who causes of hormone secretion, take to supplement the hormone of physiological dose., though the western medicine endocrine disturbance has the characteristics of instant effect, exist and take stopgap measures and can not effect a permanent cure, and have the deficiency of certain side effect.
The traditional Chinese medical science thinks, the endocrine disturbance is the performance of the deficiency of YIN, is to be caused by the QI and blood institute of being retarded by silt.Congestion is detained in body, venation is obstructed, outer poison is invaded human body, lochiostasis etc. and all may be caused the QI and blood stasis.Control suitable promoting flow of QI and blood, eliminating stagnation blood stasis removing, dredge the meridian passage.
, according to theory of Chinese medical science,, for endocrine disturbance's pathogeny, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
Exist and to cure the symptoms, not the disease and deficiency that side effect is large in order to overcome prior art western medicines in treatment endocrine disturbance, the invention provides a kind of prepare easy, cost is low, evident in efficacy, the treatment endocrine disturbance's that has no side effect Chinese medicine composition.
the technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of the endocrine disturbance, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Radix Angelicae Sinensis 10-30 part, Rhizoma Anemarrhenae 5-20 part, Radix Morindae Officinalis 5-20 part, Herba Epimedii 10-40 part, Rhizoma Curculiginis 5-20 part, Rhizoma Dioscoreae 10-40 part, Semen Ziziphi Spinosae 10-30 part, Radix Polygalae 5-20 part, Fructus Schisandrae Chinensis 5-20 part, Concha Ostreae 10-40 part, Rhizoma Atractylodis Macrocephalae 10-30 part, Radix Codonopsis 5-25 part, Poria 10-30 part, Radix Ephedrae 5-25 part, Fructus Corni 10-30 part, Fructus Psoraleae 5-25 part, Semen Cuscutae 10-30 part, Semen Nelumbinis 10-40 part, Semen Euryales 10-40 part, Radix Puerariae 5-25 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of the endocrine disturbance is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 20 parts of Radix Angelicae Sinensis, 10 parts of the Rhizoma Anemarrhenaes, 10 parts of Radix Morindae Officinaliss, 30 parts of Herba Epimedii, 10 parts of Rhizoma Curculiginises, 30 parts of Rhizoma Dioscoreaes, 20 parts of Semen Ziziphi Spinosaes, 10 parts of Radix Polygalaes, 10 parts of Fructus Schisandrae Chinensis, 30 parts of Concha Ostreaes, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Radix Codonopsis, 20 parts of Poria, 10 parts of Radix Ephedraes, 20 parts of Fructus Corni, 15 parts of Fructus Psoraleaes, 20 parts of Semen Cuscutae, 30 parts of Semen Nelumbinis, 30 parts of Semen Euryaless, 15 parts of Radix Puerariaes, 6 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience guidance, selected medicament composing prescription.In Chinese medicine composition of the present invention: Radix Angelicae Sinensis have enrich blood invigorate blood circulation, the effect of menstruction regulating and pain relieving, loosening bowel to relieve constipation; The effect that the Rhizoma Anemarrhenae has clearing away heat-fire, promotes the production of body fluid and moisturize; Radix Morindae Officinalis has the effect of reinforcing the kidney and supporting YANG, bone and muscle strengthening, expelling wind and removing dampness; Herba Epimedii has the effect of kidney-replenishing, bone and muscle strengthening, wind-damp dispelling; Rhizoma Curculiginis has the effect of reinforcing the kidney and supporting YANG, benefiting essence-blood, bone and muscle strengthening and promoting the circulation of blood detumescence; Rhizoma Dioscoreae has strengthening the spleen and tonifying the lung, stomach reinforcing the kidney invigorating, the benefit of reinforcing the kidney essence, hearing-improing and eyesight improving, help the five internal organs, bone and muscle strengthening, grow the effect that will is calmed the nerves; Semen Ziziphi Spinosae has the effect of blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation; Radix Polygalae has the Fructus Alpiniae Oxyphyllae of calming the nerves, relieving convulsion, the loose strongly fragrant effect of circulation of qi promoting of eliminating the phlegm; Fructus Schisandrae Chinensis has the effect of astringent or styptic treatment for spontaneous sweating, the supplementing QI for promoting the production of body fluid of convergence, kidney calming; Concha Ostreae has suppressing the hyperactive liver and subsiding YANG, tranquillizing the mind by relieving convulsion, hard masses softening and resolving, the astringent or styptic treatment for spontaneous sweating effect of convergence; The Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, dampness diuretic, the antiabortive effect of hidroschesis; Radix Codonopsis has the effect of invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; Poria has benefiting vital QI for tranquillizing, invigorating the spleen and regulating the stomach, dispels effect damp and hot, row water stopping leak; Radix Ephedrae has the effect of arresting sweating and strengthening superficial resistance; Fructus Corni has the effect of liver and kidney tonifying, essence astringing and desertion stemming; Fructus Psoraleae has the effect of reinforcing the kidney and supporting YANG, controlling nocturnal emission with astringent drugs reducing urination, warm spleen antidiarrheal, helping inspiration to relieve asthma; Semen Cuscutae has the effect of the kidney invigorating and essence nourishing, nourishing the liver spleen invigorating; Semen Nelumbinis has the effect of puckery clear, the tranquilizing by nourishing the heart of spleen reinforcing antidiarrheal, kidney tonifying; Semen Euryales has the effect of supplementing the kidney to control the nocturnal, spleen reinforcing antidiarrheal, damp eliminating leukorrhagia stopping; Radix Puerariae has relieving muscles diaphoresis, invigorating YANG QI to promote eruption, analgesic effect of promoting the production of body fluid; Radix Glycyrrhizae has the effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component be through dialectical compatibility, helps using mutual assistant, plays altogether the effect of the liver and the kidney tonifying, supplementing QI for promoting the production of body fluid, promoting blood circulation to remove blood stasis, dredge the meridian passage, and the treatment of Endocrine imbalance reaches treating both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, the medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose.Through the clinical practice checking, it is evident in efficacy reliable, and the property of medicine is gentle, toxic and side effects do not occur, and total effective rate reaches 92%, cure rate 62%.
The specific embodiment
The invention will be further described below in conjunction with embodiment.
Embodiment 1
A kind of Chinese medicine composition for the treatment of the endocrine disturbance, its raw material of Chinese medicine and weight proportion are: Radix Angelicae Sinensis 20g, Rhizoma Anemarrhenae 10g, Radix Morindae Officinalis 10g, Herba Epimedii 30g, Rhizoma Curculiginis 10g, Rhizoma Dioscoreae 30g, Semen Ziziphi Spinosae 20g, Radix Polygalae 10g, Fructus Schisandrae Chinensis 10g, Concha Ostreae 30g, Rhizoma Atractylodis Macrocephalae 20g, Radix Codonopsis 15g, Poria 20g, Radix Ephedrae 10g, Fructus Corni 20g, Fructus Psoraleae 15g, Semen Cuscutae 20g, Semen Nelumbinis 30g, Semen Euryales 30g, Radix Puerariae 15g, Radix Glycyrrhizae 6g.
Embodiment 2
A kind of Chinese medicine composition for the treatment of the endocrine disturbance, its raw material of Chinese medicine and weight proportion are: Radix Angelicae Sinensis 10g, Rhizoma Anemarrhenae 20g, Radix Morindae Officinalis 5g, Herba Epimedii 40g, Rhizoma Curculiginis 5g, Rhizoma Dioscoreae 40g, Semen Ziziphi Spinosae 10g, Radix Polygalae 20g, Fructus Schisandrae Chinensis 5g, Concha Ostreae 40g, Rhizoma Atractylodis Macrocephalae 10g, Radix Codonopsis 25g, Poria 10g, Radix Ephedrae 20g, Fructus Corni 10g, Fructus Psoraleae 25g, Semen Cuscutae 10g, Semen Nelumbinis 40g, Semen Euryales 10g, Radix Puerariae 25g, Radix Glycyrrhizae 10g.
Embodiment 3
A kind of Chinese medicine composition for the treatment of the endocrine disturbance, its raw material of Chinese medicine and weight proportion are: Radix Angelicae Sinensis 15g, Rhizoma Anemarrhenae 5g, Radix Morindae Officinalis 15g, Herba Epimedii 25g, Rhizoma Curculiginis 12g, Rhizoma Dioscoreae 20g, Semen Ziziphi Spinosae 15g, Radix Polygalae 5g, Fructus Schisandrae Chinensis 12g, Concha Ostreae 20g, Rhizoma Atractylodis Macrocephalae 15g, Radix Codonopsis 5g, Poria 25g, Radix Ephedrae 15g, Fructus Corni 15g, Fructus Psoraleae 10g, Semen Cuscutae 15g, Semen Nelumbinis 20g, Semen Euryales 40g, Radix Puerariae 10g, Radix Glycyrrhizae 5g.
Embodiment 4
A kind of Chinese medicine composition for the treatment of the endocrine disturbance, its raw material of Chinese medicine and weight proportion are: Radix Angelicae Sinensis 25g, Rhizoma Anemarrhenae 12g, Radix Morindae Officinalis 20g, Herba Epimedii 35g, Rhizoma Curculiginis 15g, Rhizoma Dioscoreae 30g, Semen Ziziphi Spinosae 25g, Radix Polygalae 15g, Fructus Schisandrae Chinensis 20g, Concha Ostreae 30g, Rhizoma Atractylodis Macrocephalae 25g, Radix Codonopsis 20g, Poria 15g, Radix Ephedrae 25g, Fructus Corni 25g, Fructus Psoraleae 20g, Semen Cuscutae 25g, Semen Nelumbinis 30g, Semen Euryales 20g, Radix Puerariae 5g, Radix Glycyrrhizae 12g.
Embodiment 5
A kind of Chinese medicine composition for the treatment of the endocrine disturbance, its raw material of Chinese medicine and weight proportion are: Radix Angelicae Sinensis 30g, Rhizoma Anemarrhenae 15g, Radix Morindae Officinalis 12g, Herba Epimedii 10g, Rhizoma Curculiginis 20g, Rhizoma Dioscoreae 10g, Semen Ziziphi Spinosae 30g, Radix Polygalae 12g, Fructus Schisandrae Chinensis 20g, Concha Ostreae 10g, Rhizoma Atractylodis Macrocephalae 30g, Radix Codonopsis 12g, Poria 30g, Radix Ephedrae 5g, Fructus Corni 30g, Fructus Psoraleae 5g, Semen Cuscutae 30g, Semen Nelumbinis 10g, Semen Euryales 35g, Radix Puerariae 12g, Radix Glycyrrhizae 15g.
Chinese medicine composition in embodiment of the present invention decocting method is routinely produced medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, add cold water and cover powder, soaked 15～20 minutes, then add water and do not have approximately 8 centimetres of powder, decoct for the first time, adopt intense fire to decoct before at a simmer, boil rear with slow fire boiling 20～30 minutes; Decoct for the second time, add water and do not have approximately 5 centimetres of powder, the water rear decoction 15～20 minutes of boiling.Decoct extracting juice twice, merge.
The present invention, with the given a kind of Chinese medicine composition for the treatment of the endocrine disturbance of embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 50 examples, male 12 examples, female's 38 examples, 25～55 years old age.
Two, diagnosis basis: with reference to the diagnostic criteria of endocrine disturbance in People's Republic of China's Chinese medicine industry standard " traditional Chinese medical science disease Standardization of diagnosis and curative effect ":
1, emotional factor:, when the variation that the emotion emergentness occurs, often want to fly into a rage;
2, external feature: mottle appears in face, and skin conditions worsens;
3, infertile for a long time: endocrine regulation can affect estrogenic secretion, causes female acyesis;
4, poliosis senilism: seem excessive aging, basic and actual age is not inconsistent, alopecia senilism.
Three, usage and dosage: during clinical practice, potion on the one, twice extracting juice of decocting be 400ml approximately, minute morning, late twice empty stomach decoction being taken warmly.Five days is a course for the treatment of.
Four, criterion of therapeutical effect: with reference to the endocrine disturbance's efficacy assessment standard in People's Republic of China's Chinese medicine industry standard " traditional Chinese medical science disease Standardization of diagnosis and curative effect ":
(1) recovery from illness: transference cure, sign is normal;
(2) produce effects: sx↓, sign takes a turn for the better to some extent;
(3) effective: symptom alleviates to some extent, and sign is without being clearly better;
(4) invalid: symptom is without improvement, and sign is without improvement.
Five, therapeutic effect: in this clinical observation case, take medicine 2-6 the course for the treatment of, recovery from illness 31 examples, follow up a case by regular visits to and have no recurrence; Produce effects 9 examples, effective 6 examples, invalid 4 examples.Toxic and side effects does not occur during treatment.
Six, model case:
Case 1:
Zhang, female, 36 years old.Private prosecution: face mottle occurs more than a year, and forehead also occurs in the recent period, and more and more heavier, once repeatedly treatment, but poor effect.Be diagnosed as: the endocrine disturbance.Take 2 courses for the treatment of of medicament of Chinese medicine composition preparation of the present invention, mottle obviously alleviates; Continue to take 2 courses for the treatment of, mottle disappears fully, cures.
Case 2:
The week certain, man, 42 years old.Patient's private prosecution: often want to fly into a rage, be off one's feed, hyposexuality, seem much old for sb.'s years.Be diagnosed as: the endocrine disturbance.Take 2 courses for the treatment of of medicament of Chinese medicine composition preparation of the present invention, appetite, libido are obviously improved; Continue to take 2 courses for the treatment of, symptom and sign all disappear, and cure.Follow up a case by regular visits to and do not recur half a year.
Claims (2)
1. Chinese medicine composition for the treatment of the endocrine disturbance, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: Radix Angelicae Sinensis 10-30 part, Rhizoma Anemarrhenae 5-20 part, Radix Morindae Officinalis 5-20 part, Herba Epimedii 10-40 part, Rhizoma Curculiginis 5-20 part, Rhizoma Dioscoreae 10-40 part, Semen Ziziphi Spinosae 10-30 part, Radix Polygalae 5-20 part, Fructus Schisandrae Chinensis 5-20 part, Concha Ostreae 10-40 part, Rhizoma Atractylodis Macrocephalae 10-30 part, Radix Codonopsis 5-25 part, Poria 10-30 part, Radix Ephedrae 5-25 part, Fructus Corni 10-30 part, Fructus Psoraleae 5-25 part, Semen Cuscutae 10-30 part, Semen Nelumbinis 10-40 part, Semen Euryales 10-40 part, Radix Puerariae 5-25 part, Radix Glycyrrhizae 5-15 part.
2. a kind of Chinese medicine composition for the treatment of the endocrine disturbance according to claim 1, it is characterized in that: its raw material of Chinese medicine and weight portion proportioning are: 20 parts of Radix Angelicae Sinensis, 10 parts of the Rhizoma Anemarrhenaes, 10 parts of Radix Morindae Officinaliss, 30 parts of Herba Epimedii, 10 parts of Rhizoma Curculiginises, 30 parts of Rhizoma Dioscoreaes, 20 parts of Semen Ziziphi Spinosaes, 10 parts of Radix Polygalaes, 10 parts of Fructus Schisandrae Chinensis, 30 parts of Concha Ostreaes, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 15 parts of Radix Codonopsis, 20 parts of Poria, 10 parts of Radix Ephedraes, 20 parts of Fructus Corni, 15 parts of Fructus Psoraleaes, 20 parts of Semen Cuscutae, 30 parts of Semen Nelumbinis, 30 parts of Semen Euryaless, 15 parts of Radix Puerariaes, 6 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310313282.6A CN103386008B (en) | 2013-07-24 | 2013-07-24 | Chinese medicine composition for treating endocrine dyscrasia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310313282.6A CN103386008B (en) | 2013-07-24 | 2013-07-24 | Chinese medicine composition for treating endocrine dyscrasia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103386008A true CN103386008A (en) | 2013-11-13 |
| CN103386008B CN103386008B (en) | 2015-04-01 |
Family
ID=49530543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310313282.6A Expired - Fee Related CN103386008B (en) | 2013-07-24 | 2013-07-24 | Chinese medicine composition for treating endocrine dyscrasia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103386008B (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104096074A (en) * | 2014-06-05 | 2014-10-15 | 张金城 | Chinese medicinal composition for treatment of endocrine dyscrasia |
| CN104107395A (en) * | 2014-07-24 | 2014-10-22 | 王浩 | Traditional Chinese medicine composition for treating endocrine dyscrasia |
| CN104524332A (en) * | 2014-12-25 | 2015-04-22 | 张冬梅 | Traditional Chinese medicine for treating endocrine dyscrasia |
| CN104587195A (en) * | 2015-02-15 | 2015-05-06 | 孙红梅 | Traditional Chinese medicine composition for treating endocrine dyscrasia |
| CN104606470A (en) * | 2015-02-15 | 2015-05-13 | 赵世明 | Traditional Chinese medicine composition for treating endocrine dyscrasia |
| CN104721649A (en) * | 2015-04-15 | 2015-06-24 | 邵明冉 | Traditional Chinese medicine for treating endocrine dyscrasia |
| CN105477450A (en) * | 2015-12-31 | 2016-04-13 | 刘婵琳 | Traditional Chinese medicine for treating endocrine dyscrasia |
| CN105709097A (en) * | 2016-03-14 | 2016-06-29 | 马尊良 | Traditional Chinese medicine composition for treating endocrine dyscrasia and preparation method thereof |
| CN105727072A (en) * | 2016-03-11 | 2016-07-06 | 魏进 | Chinese herbal medicine for treating endocrine dyscrasia and its preparation method |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1184659A (en) * | 1997-11-14 | 1998-06-17 | 张锡昆 | Traditional Chinese medicine for invigorating kidney and strengthening the spleen and stomach |
| CN1279090A (en) * | 1999-06-25 | 2001-01-10 | 刘永香 | Powdered medicine for conditioning viscera and whole body |
| CN1660404A (en) * | 2005-01-19 | 2005-08-31 | 雷小平 | Health product of preserving health, invigorating the kidney and supporting yang for male |
| CN1679656A (en) * | 2004-04-08 | 2005-10-12 | 北京天和润物中医药研究所 | Prescription of ecologic synchronous treatment |
| CN101695545A (en) * | 2009-08-25 | 2010-04-21 | 李永胜 | Anti-aging, antifatigue and essential qi-supplementing granules and capsules |
| CN102406834A (en) * | 2011-12-05 | 2012-04-11 | 哈尔滨济博生物技术开发有限公司 | Medicament for treating Yang deficiency of women menopause syndrome |
| CN102698104A (en) * | 2012-06-06 | 2012-10-03 | 张俊波 | Medicine for treating climacteric syndrome and preparation method |
-
2013
- 2013-07-24 CN CN201310313282.6A patent/CN103386008B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1184659A (en) * | 1997-11-14 | 1998-06-17 | 张锡昆 | Traditional Chinese medicine for invigorating kidney and strengthening the spleen and stomach |
| CN1279090A (en) * | 1999-06-25 | 2001-01-10 | 刘永香 | Powdered medicine for conditioning viscera and whole body |
| CN1679656A (en) * | 2004-04-08 | 2005-10-12 | 北京天和润物中医药研究所 | Prescription of ecologic synchronous treatment |
| CN1660404A (en) * | 2005-01-19 | 2005-08-31 | 雷小平 | Health product of preserving health, invigorating the kidney and supporting yang for male |
| CN101695545A (en) * | 2009-08-25 | 2010-04-21 | 李永胜 | Anti-aging, antifatigue and essential qi-supplementing granules and capsules |
| CN102406834A (en) * | 2011-12-05 | 2012-04-11 | 哈尔滨济博生物技术开发有限公司 | Medicament for treating Yang deficiency of women menopause syndrome |
| CN102698104A (en) * | 2012-06-06 | 2012-10-03 | 张俊波 | Medicine for treating climacteric syndrome and preparation method |
Non-Patent Citations (5)
| Title |
|---|
| 仇新军等: "中医辨证治疗女性更年期综合症64 例", 《河北中医药学报》, vol. 19, no. 2, 31 December 2004 (2004-12-31), pages 14 - 15 * |
| 卢山: "黄褐斑的中医辨证论治", 《现代医药卫生》, vol. 28, no. 14, 30 July 2012 (2012-07-30), pages 2213 - 2214 * |
| 孙毓蔓: "42例内分泌失调性骨质疏松症临床治疗分析", 《当代医学》, vol. 18, no. 35, 31 December 2012 (2012-12-31), pages 153 - 154 * |
| 杨晓勇: "仙茅汤加味治疗男性更年期综合症48 例", 《湖南中医杂志》, vol. 18, no. 5, 30 September 2002 (2002-09-30), pages 32 * |
| 覃永健等: "中医治疗黄褐斑内服方剂组方规律探讨", 《广西中医药》, vol. 35, no. 1, 28 February 2012 (2012-02-28), pages 36 - 38 * |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104096074A (en) * | 2014-06-05 | 2014-10-15 | 张金城 | Chinese medicinal composition for treatment of endocrine dyscrasia |
| CN104107395A (en) * | 2014-07-24 | 2014-10-22 | 王浩 | Traditional Chinese medicine composition for treating endocrine dyscrasia |
| CN104524332A (en) * | 2014-12-25 | 2015-04-22 | 张冬梅 | Traditional Chinese medicine for treating endocrine dyscrasia |
| CN104587195A (en) * | 2015-02-15 | 2015-05-06 | 孙红梅 | Traditional Chinese medicine composition for treating endocrine dyscrasia |
| CN104606470A (en) * | 2015-02-15 | 2015-05-13 | 赵世明 | Traditional Chinese medicine composition for treating endocrine dyscrasia |
| CN104721649A (en) * | 2015-04-15 | 2015-06-24 | 邵明冉 | Traditional Chinese medicine for treating endocrine dyscrasia |
| CN105477450A (en) * | 2015-12-31 | 2016-04-13 | 刘婵琳 | Traditional Chinese medicine for treating endocrine dyscrasia |
| CN105727072A (en) * | 2016-03-11 | 2016-07-06 | 魏进 | Chinese herbal medicine for treating endocrine dyscrasia and its preparation method |
| CN105709097A (en) * | 2016-03-14 | 2016-06-29 | 马尊良 | Traditional Chinese medicine composition for treating endocrine dyscrasia and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103386008B (en) | 2015-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386008B (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN103211892B (en) | Chinese medicinal composition for treating insomnia | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN104107395A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN103705866A (en) | Traditional Chinese medicine composition for treating hypomenorrhea | |
| CN103550495B (en) | A kind of Chinese medicine composition of Cure for insomnia | |
| CN103386088A (en) | Chinese medicine composition for treating insomnia | |
| CN103330805A (en) | Traditional Chinese medicine composition for treating menorrhagia | |
| CN104043049A (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN104606470A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN104173565A (en) | Traditional Chinese medicine composition for treating irregular menstruation | |
| CN105288116A (en) | Traditional Chinese medicine composition for treating schizophrenia | |
| CN103251861B (en) | Traditional Chinese medicine composition for treating headache | |
| CN104623232A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN103721082A (en) | Traditional Chinese medicinal composition for treating scapulohumeral periarthritis | |
| CN103705900A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN105749167A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN102293946A (en) | Chinese medicinal composition for treating vertigo | |
| CN104758674A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN103736027A (en) | Traditional Chinese medicine composition for treating insomnia | |
| CN103690925A (en) | Traditional Chinese medicinal composition for treating amenorrhea | |
| CN103550533A (en) | Chinese medicine composition for treating headache during menstruation | |
| CN103816493B (en) | A kind of Chinese medicine composition treating instability of kidney QI | |
| CN103285108B (en) | Chinese medicinal composition treating lumbago |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: MA LIZHUANG Free format text: FORMER OWNER: ZHAO SHIMING Effective date: 20150210 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ma Lizhuang Inventor after: Zhao Shiming Inventor after: Zhang Xia Inventor after: Liu Jingyuan Inventor before: Zhao Shiming Inventor before: Zhang Xia Inventor before: Liu Jingyuan |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHAO SHIMING ZHANG XIA LIU JINGYUAN TO: MA LIZHUANG ZHAO SHIMING ZHANG XIALIU JINGYUAN Free format text: CORRECT: ADDRESS; FROM: 264316 WEIHAI, SHANDONG PROVINCE TO: 264309 WEIHAI, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150210 Address after: 264309 Shidao, Shandong, China, the new city of Rongcheng Double Road East, No. 199 Applicant after: Ma Lizhuang Address before: 264316, No. 500, search mountain road, Weihai, Shandong, Rongcheng Applicant before: Zhao Shiming |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150401 Termination date: 20150724 |
|
| EXPY | Termination of patent right or utility model |